Acute respiratory failure and diffuse pulmonary infiltrates four weeks after rituximab therapy

Hadi H. Hatoum, George A. Sarosi, Kenneth S. Knox, Chadi Hage

Research output: Contribution to journalArticle

Abstract

We report a 51-year-old woman with known SLE on low dose prednisone, recently started on rituximab, who presents with acute respiratory failure and bilateral air space disease. After an initial treatment with broad spectrum antibiotics for healthcare-associated pneumonia and negative serologic studies, a diagnosis of pneumocystis pneumonia was established using bronchoalveolar lavage. We suggest that rituximab can be an aggravating cause of pneumocystis in patients treated with prednisone.

Original languageEnglish (US)
Pages (from-to)134-136
Number of pages3
JournalRespiratory Medicine CME
Volume2
Issue number3
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Prednisone
Respiratory Insufficiency
Pneumocystis
Lung
Pneumocystis Pneumonia
Bronchoalveolar Lavage
Pneumonia
Air
Anti-Bacterial Agents
Delivery of Health Care
Therapeutics
Rituximab

Keywords

  • Pneumocystis pneumonia
  • Rituximab

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Acute respiratory failure and diffuse pulmonary infiltrates four weeks after rituximab therapy. / Hatoum, Hadi H.; Sarosi, George A.; Knox, Kenneth S.; Hage, Chadi.

In: Respiratory Medicine CME, Vol. 2, No. 3, 2009, p. 134-136.

Research output: Contribution to journalArticle

Hatoum, Hadi H. ; Sarosi, George A. ; Knox, Kenneth S. ; Hage, Chadi. / Acute respiratory failure and diffuse pulmonary infiltrates four weeks after rituximab therapy. In: Respiratory Medicine CME. 2009 ; Vol. 2, No. 3. pp. 134-136.
@article{7a451c06b96c4cbb9702cd4a0fd11264,
title = "Acute respiratory failure and diffuse pulmonary infiltrates four weeks after rituximab therapy",
abstract = "We report a 51-year-old woman with known SLE on low dose prednisone, recently started on rituximab, who presents with acute respiratory failure and bilateral air space disease. After an initial treatment with broad spectrum antibiotics for healthcare-associated pneumonia and negative serologic studies, a diagnosis of pneumocystis pneumonia was established using bronchoalveolar lavage. We suggest that rituximab can be an aggravating cause of pneumocystis in patients treated with prednisone.",
keywords = "Pneumocystis pneumonia, Rituximab",
author = "Hatoum, {Hadi H.} and Sarosi, {George A.} and Knox, {Kenneth S.} and Chadi Hage",
year = "2009",
doi = "10.1016/j.rmedc.2008.12.004",
language = "English (US)",
volume = "2",
pages = "134--136",
journal = "Respiratory Medicine Case Reports",
issn = "2213-0071",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Acute respiratory failure and diffuse pulmonary infiltrates four weeks after rituximab therapy

AU - Hatoum, Hadi H.

AU - Sarosi, George A.

AU - Knox, Kenneth S.

AU - Hage, Chadi

PY - 2009

Y1 - 2009

N2 - We report a 51-year-old woman with known SLE on low dose prednisone, recently started on rituximab, who presents with acute respiratory failure and bilateral air space disease. After an initial treatment with broad spectrum antibiotics for healthcare-associated pneumonia and negative serologic studies, a diagnosis of pneumocystis pneumonia was established using bronchoalveolar lavage. We suggest that rituximab can be an aggravating cause of pneumocystis in patients treated with prednisone.

AB - We report a 51-year-old woman with known SLE on low dose prednisone, recently started on rituximab, who presents with acute respiratory failure and bilateral air space disease. After an initial treatment with broad spectrum antibiotics for healthcare-associated pneumonia and negative serologic studies, a diagnosis of pneumocystis pneumonia was established using bronchoalveolar lavage. We suggest that rituximab can be an aggravating cause of pneumocystis in patients treated with prednisone.

KW - Pneumocystis pneumonia

KW - Rituximab

UR - http://www.scopus.com/inward/record.url?scp=66449129613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66449129613&partnerID=8YFLogxK

U2 - 10.1016/j.rmedc.2008.12.004

DO - 10.1016/j.rmedc.2008.12.004

M3 - Article

VL - 2

SP - 134

EP - 136

JO - Respiratory Medicine Case Reports

JF - Respiratory Medicine Case Reports

SN - 2213-0071

IS - 3

ER -